Gliomas: New perspectives in diagnosis, treatment and prognosis

Kemel A. Ghotme*, George E. Barreto, Valentina Echeverria, Janneth Gonzalez, Rosa H. Bustos, Magdy Sanchez, Jerzy Leszek, Nagendra Sastry Yarla, Rosa Margarita Gomez, Vadim V. Tarasov, Ghulam Md Ashraf, Gjumrakch Aliev

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

56 Citations (Scopus)

Abstract

Gliomas are central nervous system tumors originated from glial cells, whose incidence and mortality is expected to rise in coming years, especially in developing countries. Diagnosis and classification of gliomas have largely relied on tumor histopathologic features that provide limited information regarding response to therapy or prognosis. Current treatment of gliomas is surgery combined with chemotherapy and/or radiotherapy. However, many tumors show a high resistance to these interventions, and recurrences are frequent since conventional therapies do not take into account the unique molecular features of different subtypes of glioma. Molecular genetics provide new insights in classifying gliomas and predicting response to therapy that can range from conventional treatments to new revolutionary therapeutic approaches. This article offers a review of the intracellular signaling pathways involved in carcinogenesis of gliomas, as well as a description of new tools for their diagnosis, prognosis, and treatment with a target-oriented approach.

Original languageEnglish
Pages (from-to)1438-1447
Number of pages10
JournalCurrent Topics in Medicinal Chemistry
Volume17
Issue number12
DOIs
Publication statusPublished - 1 Apr 2017
Externally publishedYes

Keywords

  • Biomarkers
  • Genotype
  • Glioma
  • Gliomagenesis
  • Phenotype
  • Prognosis
  • Signaling pathways
  • Treatment

Fingerprint

Dive into the research topics of 'Gliomas: New perspectives in diagnosis, treatment and prognosis'. Together they form a unique fingerprint.

Cite this